| Dr Vincent T Leon, MD | |
|
1301 Punchbowl St, Honolulu, HI 96813-2402 | |
| (808) 538-9011 | |
| Not Available |
| Full Name | Dr Vincent T Leon |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 1301 Punchbowl St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043259047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD9785 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Queens Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Queens University Medical Group | 2466831557 | 543 |
News Archive
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Intercell AG has announced that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started.
The Centers for Disease Control and Prevention (CDC) recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.
› Verified 3 days ago
| Entity Name | The Queens Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693586 PECOS PAC ID: 3476454067 Enrollment ID: O20040116000366 |
News Archive
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Intercell AG has announced that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started.
The Centers for Disease Control and Prevention (CDC) recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.
› Verified 3 days ago
| Entity Name | Queens Development Corporation & Subsidiaries |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679768352 PECOS PAC ID: 7810912292 Enrollment ID: O20071030000445 |
News Archive
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Intercell AG has announced that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started.
The Centers for Disease Control and Prevention (CDC) recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.
› Verified 3 days ago
| Entity Name | Queens University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891441382 PECOS PAC ID: 2466831557 Enrollment ID: O20220621000534 |
News Archive
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Intercell AG has announced that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started.
The Centers for Disease Control and Prevention (CDC) recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vincent T Leon, MD Po Box 29640, Honolulu, HI 96820-2040 Ph: () - | Dr Vincent T Leon, MD 1301 Punchbowl St, Honolulu, HI 96813-2402 Ph: (808) 538-9011 |
News Archive
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Intercell AG has announced that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started.
The Centers for Disease Control and Prevention (CDC) recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.
› Verified 3 days ago
Qi Zhi, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2230 Liliha St Ste 104, Honolulu, HI 96817 Phone: 808-261-4476 | |
Pantea Shoja, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1860 Ala Moana Blvd, #101, Honolulu, HI 96815 Phone: 808-921-2273 Fax: 808-921-2274 | |
Christina L Poon, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2226 Liliha St Ste 308, Honolulu, HI 96817 Phone: 808-892-4361 | |
Dr. Jennifer Junnila Walker, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Road, Tripler Amc, Striper Army Medical Center, Honolulu, HI 96859 Phone: 808-433-8500 Fax: 808-433-8505 | |
Dr. Lauren I Okamoto, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 347 N Kuakini St, Hpm 9, Honolulu, HI 96817 Phone: 808-523-8461 | |
Dr. John Albion Benson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Honolulu, HI 96859 Phone: 808-433-8850 | |
Dr. Mary Kathleen Gaynor, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1132 Bishop St, Suite 1900, Honolulu, HI 96813 Phone: 808-587-5879 |